Ramipril modified release - Panacea BiotecAlternative Names: Ramipril extended release - Panacea Biotec; Ramipril MR - Panacea Biotec; Ramy 24; Ramy24
Latest Information Update: 22 Feb 2016
At a glance
- Originator Panacea Biotec
- Class Antihypertensives; Heart failure therapies; Heterocyclic bicyclo compounds; Small molecules
- Mechanism of Action ACE inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Hypertension
Most Recent Events
- 15 Mar 2016 Biomarkers information updated
- 23 Aug 2011 Panacea Biotec completes a phase III trial in Hypertension in India (CTRI/2009/091/000591)